Ionis Pharmaceuticals | IONS - Cash And Equivalent


Ionis Pharmaceuticals reported $1.92B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Agios Pharmaceuticals USD 113.6M 24.47M Mar/2026
Alnylam Pharmaceuticals USD 1.71B 53.53M Mar/2026
Arrowhead Research USD 201.64M 112.94M Dec/2025
Astellas Pharma JPY 188.37B 8.51B Mar/2025
BioCryst Pharmaceuticals USD 171.59M 164.32M Mar/2026
BioMarin Pharmaceutical USD 2.22B 910.76M Mar/2026
Celltrion KRW 49.87B 20.22B Dec/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Esperion Therapeutics USD 156.16M 11.69M Mar/2026
Exelixis USD 226.15M 256.34M Mar/2026
Halozyme Therapeutics USD 309.75M 175.93M Mar/2026
Ionis Pharmaceuticals USD 1.92B 758M Mar/2026
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Moderna USD 1.91B 687M Mar/2026
Nektar Therapeutics USD 15.12M 25.92M Dec/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Neurocrine Biosciences USD 266.5M 446.5M Mar/2026
Novartis USD 6.88B 4.56B Mar/2026
Omeros USD 1.9M 2.36M Jun/2025
OPKO Health USD 369.1M 42.87M Dec/2025
Organigram Holdings CAD 7.58M 20.62M Dec/2025
Pfizer USD 1.7B 561M Mar/2026
Pharma Mar EUR 48.86M 31.05M Mar/2026
PTC Therapeutics USD 833.99M 150.66M Mar/2026
Qiagen NV USD 839M 516.58M Dec/2025
Regeneron Pharmaceuticals USD 2.96B 15.9B Mar/2026
Roche Holding CHF 7.55B 579M Jun/2025
Sarepta Therapeutics USD 464.45M 336.83M Mar/2026
Sartorius EUR 573.8M 32.4M Mar/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Tilray USD 264.83M 43.16M Jun/2025
Ultragenyx Pharmaceutical USD 175M 246M Mar/2026
Vertex Pharmaceuticals USD 7.25B 638.6M Mar/2026
Zealand Pharma A/S 4.58B 1.4B Dec/2025
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026